Published September 10, 2018 | Version v1
Dataset Open

Screening Compounds against USP5 Zf-UBD with a 19F NMR assay #2

  • 1. University of Toronto, Structural Genomics Consortium
  • 2. University Health Network

Description

Screening compounds against USP5 zinc finger ubiquitin binding domain (Zf-UBD) using a 19F NMR spectroscopy. You can find previous 19F NMR experiments here.

Notes

Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

Files

1NMR Screen.pdf

Files (1.3 MB)

Name Size Download all
md5:9de12dd009080fb40f2a8cdaac2546d3
657.5 kB Preview Download
md5:a370418243e3cb26d54957cfb601a1e1
648.2 kB Preview Download